Literature DB >> 25805361

Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role of NADPH oxidase.

Lorenzo Loffredo1, Anna Maria Zicari2, Francesca Occasi2, Ludovica Perri3, Roberto Carnevale3, Francesco Angelico4, Maria Del Ben3, Francesco Martino2, Cristina Nocella3, Vincenzo Savastano2, Azzurra Cesoni Marcelli2, Marzia Duse2, Francesco Violi3.   

Abstract

OBJECTIVE: Oxidative stress plays a crucial role in impairing endothelial function in sleep disordered breathing (SDB) but the underlying mechanism is still undefined. The objective of this study was to evaluate the interplay between oxidative stress, assessed by serum isoprostanes (8-iso-PGF2α) and soluble NOX2-dp (sNOX2-dp), and endothelial function, assessed by flow-mediated dilation (FMD), in children with SDB and healthy controls (HC).
METHODS: One-hundred forty-four children including 45 with primary snoring (PS), 22 with obstructive sleep apnea (OSA) and 67 HC were recruited in this study; in 15 out of 22 OSA children FMD, serum 8-iso-PGF2α and sNOX2-dp were assessed before and after one month post adeno-tonsillectomy (AT).
RESULTS: Compared with HC, OSA and PS children had significantly higher sNOX2-dp and serum 8-iso-PGF2α levels and lower FMD; compared with PS, FMD was significantly lower in OSA children. No significant difference for sNOX2-dp and serum 8-iso-PGF2α was observed between OSA and PS children. FMD was inversely correlated with sNOX2-dp levels (p<0.001) and with serum 8-iso-PGF2α (p<0.001). In multiple linear regression analysis, sNOX2-dp (p<0.001) and serum 8-iso-PGF2α (p<0.001) were the only independent predictive variables associated with FMD. AT significantly decreased sNOX2-dp and serum 8-iso-PGF2α levels (from 38.2±8.8 to 22.4±11.1 pg/ml, p<0.001, and from 281.4±69.7 to 226.0±66.4 pg/ml, p<0.001, respectively); conversely, FMD significantly increased after AT in OSA children (from 3.0±1.5 to 8.0±2.8%, p<0.001).
CONCLUSION: This study suggests that NOX2-derived oxidative stress is involved in artery dysfunction in SDB children. Such hypothesis is reinforced by FMD improvement after AT coincidentally with oxidative stress lowering. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02247167.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Endothelial function; Oxidative stress; Sleep disorder breathing

Mesh:

Substances:

Year:  2015        PMID: 25805361     DOI: 10.1016/j.atherosclerosis.2015.03.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  24 in total

Review 1.  Update on paediatric obstructive sleep apnoea.

Authors:  Eleonora Dehlink; Hui-Leng Tan
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

Review 2.  Pediatric OSA Syndrome Morbidity Biomarkers: The Hunt Is Finally On!

Authors:  Leila Kheirandish-Gozal; David Gozal
Journal:  Chest       Date:  2016-10-06       Impact factor: 9.410

3.  Indoor/outdoor not-voluptuary-habit pollution and sleep-disordered breathing in children: a systematic review.

Authors:  Laura Tenero; Giorgio Piacentini; Luana Nosetti; Emma Gasperi; Michele Piazza; Marco Zaffanello
Journal:  Transl Pediatr       Date:  2017-04

4.  Ascending aortic blood flow velocity is increased in children with primary snoring/mild sleep-disordered breathing and associated with an increase in CD8 +  T cells expressing TNFα and IFNγ.

Authors:  Anna Kontos; Scott Willoughby; Cameron van den Heuvel; Declan Kennedy; James Martin; Greg Hodge; Matthew Worthley; Adelene Kaihui Chin; Adam Nelson; Karen Teo; Mathias Baumert; Yvonne Pamula; Kurt Lushington
Journal:  Heart Vessels       Date:  2017-11-22       Impact factor: 2.037

5.  Nocturnal blood pressure fluctuations measured by using pulse transit time in patients with severe obstructive sleep apnea syndrome.

Authors:  Jennifer Gehring; Heiko Gesche; Gesine Drewniok; Gert Küchler; Andreas Patzak
Journal:  Sleep Breath       Date:  2017-08-22       Impact factor: 2.816

Review 6.  Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies.

Authors:  Anthony L Sylvester; David X Zhang; Sophia Ran; Natalya S Zinkevich
Journal:  Biomolecules       Date:  2022-06-13

7.  Effect of CPAP therapy on nocturnal blood pressure fluctuations, nocturnal blood pressure, and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea.

Authors:  Frauke Picard; Petroula Panagiotidou; Laura Weinig; Maximilian Steffen; Anne-Beke Tammen; Rolf Michael Klein
Journal:  Sleep Breath       Date:  2020-04-15       Impact factor: 2.816

Review 8.  The cardiovascular risk in paediatrics: the paradigm of the obstructive sleep apnoea syndrome.

Authors:  Marco Zaffanello; Giorgio Piacentini; Stefania La Grutta
Journal:  Blood Transfus       Date:  2020-03-17       Impact factor: 3.443

Review 9.  Sleep Disordered Breathing in Children.

Authors:  Christopher Grime; Hui-leng Tan
Journal:  Indian J Pediatr       Date:  2015-09-07       Impact factor: 1.967

Review 10.  Cardiovascular Disorders Triggered by Obstructive Sleep Apnea-A Focus on Endothelium and Blood Components.

Authors:  Jakub Mochol; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Helena Martynowicz; Adrian Doroszko
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.